EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today reported that its marketing partner, Ferring Pharmaceuticals, has been awarded the 2008 Frost and Sullivan European Human Growth Hormone Competitive Strategy Leadership Award. The award is in recognition of Ferring’s initiatives in providing needle-free injection for human growth hormone (hGH), which uses Antares proprietary VISION® device.
